Differential Regulation of CELA2A in the Stomach and Jejunum During Obesity

Overview

Revise to specify the implications of CELA2A regulation in metabolic signaling related to obesity and RYGB.

Background

Obesity is a significant global health issue linked to various metabolic disorders, including type 2 diabetes (T2D). Roux-en-Y gastric bypass (RYGB) is an effective surgical intervention that not only promotes weight loss but also induces rapid improvements in glycemic control. Understanding the molecular mechanisms behind these changes, particularly the role of proteins like CELA2A, is crucial for enhancing therapeutic strategies.

Data Highlights

Key Findings

• CELA2A expression increases in gastric mucosa post-RYGB.
• Jejunal CELA2A levels decrease after RYGB.
• Before surgery, jejunal CELA2A is positively associated with HbA1c levels.
• In high-fat diet-fed mice, jejunal CELA2A expression is elevated.
• CELA2A immunoreactivity is found in mucosal glandular structures of both stomach and jejunum.

Clinical Implications

The differential regulation of CELA2A in gastrointestinal tissues suggests its potential role in metabolic signaling pathways post-bariatric surgery. Clinicians should consider the implications of CELA2A levels when evaluating metabolic outcomes in patients undergoing RYGB.

Conclusion

Highlight the necessity for further research on CELA2A's role in glucose homeostasis.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. Author(s)/Org, Source, Year -- Title
6. Obesity Surgery — The Role of Bile in the Biliopancreatic Limb for Enhancing Metabolic Outcomes Following Duodenal-Jejunal Bypass
7. 2022 ASMBS/IFSO Indications for Metabolic and Bariatric Surgery
8. Bariatric Surgery versus Intensive Medical Therapy for Diabetes
9. Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia | Nature Reviews Endocrinology